Julianne Bruno
Equibles does not estimate personal net worth.
Get an email with a short summary when CRISPR Therapeutics AG publishes a filing, an earnings call transcript or a press release.
Get CRSP alertsAbout Julianne Bruno
Julianne Bruno is recorded as COO at CRISPR Therapeutics AG (CRSP) since May 23, 2024. CRISPR Therapeutics AG reported in an 8-K filed March 26, 2025 that Julianne Bruno resigned as Chief Operating Officer, effective April 11, 2025. CRISPR Therapeutics AG reported in an 8-K filed May 23, 2024 that Julianne Bruno was appointed Chief Operating Officer, effective May 23, 2024. CRISPR Therapeutics AG is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CRISPR Therapeutics AG includes Samarth Kulkarni (CEO), Samarth Kulkarni, Ph.D. (Chairman), Andrew J. Silver (CFO and Chief Accounting Officer) and 7 others.
“On March 24, 2025, Julianne Bruno informed CRISPR Therapeutics AG (the "Company") that she would be stepping down from the Company to pursue external opportunities, effective as of April 11, 2025, and she resigned from her position as Chief Operating Officer of the Company.”
“On May 23, 2024, CRISPR Therapeutics AG (the "Company") announced the promotion of Julianne Bruno, currently the Company's Senior Vice President and Head of Programs & Portfolio, to be the Company's Chief Operating Officer effective as of May 23, 2024.”
Affiliation history
-
Current
2024-05-23–present
-
2024-05-23–2025-04-11
Company network
Leadership on record at CRISPR Therapeutics AG
- Samarth Kulkarni CEO
- Samarth Kulkarni, Ph.D. Chairman
- Andrew J. Silver CFO, Chief Accounting Officer
- Raju Prasad CFO
- Raju Prasad, Ph.D. CFO, Chief Accounting Officer
- James R. Kasinger General Counsel
- Ali Behbahani Board Member
- Briggs W. Morrison Board Member
- Christian Rommel Board Member
- Christian Rommel, Ph.D. Board Member